Sixty‐six patients were entered into a prospective, randomized clinical trial evaluating the
use of alternating noncross‐resistant chemotherapy in patients with extensive small cell …

The National Cancer Institute of Canada Clinical Trials Group conducted a prospective
randomized study comparing standard chemotherapy with alternating chemotherapy in …

After stratification for extent of small cell lung cancer, 109 patients were randomized to
receive cycles of chemotherapy with cyclophosphamide, doxorubicin, and VP-16-213 …

Two chemotherapy regimens for patients with extensive small-cell lung cancer were
prospectively compared in a randomized multicentric trial with crossover. Every four weeks …

One hundred forty-seven eligible patients with small-cell carcinoma of the lung (SCCL) have
been randomized to receive alternating (A) or sequential (S) combination chemotherapy …

Alternating chemotherapy for small cell lung cancer has been tested in several studies.
Some have shown positive results that have not been confirmed in other studies. In all of the …

PURPOSE The trial was undertaken to determine (1) the relative efficacy/toxicity of two
commonly used combination chemotherapy regimens in patients with extensive small-cell …

It has become clear from many studies that small-cell carcinoma of the lung (SCCL) is highly
responsive to combination chemotherapy regimes with or without radiation therapy (1-7, 10 …

Abstract From April, 1979 to November, 1981, 293 patients with small cell lung carcinoma
(SCLC) were entered on a randomized, controlled study comparing the two induction …

Abstract In a 2-year period, 146 patients with small cell carcinoma of the lung, staged as
having extensive disease, were randomized to receive either continuous chemotherapy …